Cargando…
Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease
Plasma free fatty acid (FFA) concentration is elevated in obesity, insulin resistance (IR), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and related comorbidities such as cardiovascular disease (CVD). Furthermore, experimentally manipulating plasma FFA in the laboratory setting...
Autor principal: | Henderson, Gregory C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402049/ https://www.ncbi.nlm.nih.gov/pubmed/34444750 http://dx.doi.org/10.3390/nu13082590 |
Ejemplares similares
-
Albumin knockout mice exhibit reduced plasma free fatty acid concentration and enhanced insulin sensitivity
por: Abdollahi, Afsoun, et al.
Publicado: (2022) -
Effect of rosuvastatin on the concentration of each fatty acid in the fraction of free fatty acids and total lipids in human plasma: The role of cholesterol homeostasis
por: Ciucanu, Cristian I., et al.
Publicado: (2020) -
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
por: I. S. Sobczak, Amélie, et al.
Publicado: (2019) -
Concentrations of Plasma Free Palmitoleic and Dihomo-Gamma Linoleic Fatty Acids Are Higher in Children with Abdominal Obesity
por: Aristizabal, Juan C., et al.
Publicado: (2018) -
Biomechanism of chlorogenic acid complex mediated plasma free fatty acid metabolism in rat liver
por: H.V., Sudeep, et al.
Publicado: (2016)